Avalo Therapeutics (AVTX) Intangibles (2017 - 2021)
Avalo Therapeutics posted quarterly Intangibles of $38000.0 for Q4 2021, down 97.6% year-on-year from $1.6 million in Q4 2020, and down 87.5% on a QoQ basis from $304000.0 in Q3 2021.
Avalo Therapeutics (AVTX) has 5 years of Intangibles data on file, last reported at $38000.0 in Q4 2021.
- For the quarter ending Q4 2021, Intangibles fell 97.6% year-over-year to $38000.0; the trailing twelve-month figure through Dec 2021 stood at $38000.0 (down 97.6% YoY), and the FY2021 full-year result was $38000.0, down 97.6% from the prior year.
- Intangibles for Q4 2021 stood at $38000.0, down from $304000.0 in the prior quarter.
- Across five years, Intangibles topped out at $33.1 million in Q1 2018 and bottomed at $38000.0 in Q4 2021.
- The 5-year median for Intangibles is $2.4 million (2019), against an average of $12.6 million.
- Peak annual rise in Intangibles reached 29.0% in 2021, while the deepest fall reached 97.6% in 2021.
- A 5-year view of Intangibles shows it stood at $17.7 million in 2017, then slumped by 78.68% to $3.8 million in 2018, then plunged by 35.57% to $2.4 million in 2019, then plunged by 34.67% to $1.6 million in 2020, then plunged by 97.6% to $38000.0 in 2021.
- The last three Intangibles figures came in at $38000.0 (Q4 2021), $304000.0 (Q3 2021), and $732000.0 (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 304,000.00 |
| Jun 30, 2021 | 732,000.00 |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.89 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Mar 31, 2020 | 900,000.00 |
| Dec 31, 2019 | 2.43 Mn |
| Sep 30, 2019 | 26.60 Mn |
| Jun 30, 2019 | 27.63 Mn |
| Mar 31, 2019 | 30.16 Mn |
| Dec 31, 2018 | 3.77 Mn |
| Sep 30, 2018 | 32.46 Mn |
| Jun 30, 2018 | 32.00 Mn |
| Mar 31, 2018 | 33.10 Mn |
| Dec 31, 2017 | 17.66 Mn |